Effectiveness of roflumilast, a phosphodiesterase type-4 (PDE4) inhibitor on biomarkers of inflammation in COPD

被引：0

作者：

Savelikhina, Iryna ^{[1
]}

Ostrovskyy, Mykola ^{[1
]}

Zuban, Alla ^{[1
]}

Varunkiv, Oleksandr ^{[1
]}

Kulynych-Miskiv, Mariana ^{[1
]}

Shvets, Kostiantyn ^{[1
]}

Korzh, Galyna ^{[1
]}

Makoyda, Iryna ^{[1
]}

Korzh, Nadiia ^{[1
]}

Shevchuk-Budz, Uliana ^{[1
]}

机构：

[1] Ivano Frankivsk Natl Med Univ, Ivano Frankivsk, Ukraine

来源：

EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷

关键词：

D O I：

10.1183/13993003.congress-2023.PA1306

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：2

共 50 条

[21] Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD
Rennard, Stephen I.
Calverley, Peter M. A.
Goehring, Udo M.
Bredenbroeker, Dirk
Martinez, Fernando J.
RESPIRATORY RESEARCH, 2011, 12
[22] The PDE4 inhibitor roflumilast provides additional clinical benefit in COPD patients treated with tiotropium
Kroker, A.
Gehling, U.
Bethke, T. D.
Gooss, A.
Rabe, K. F.
SWISS MEDICAL WEEKLY, 2010, 140 (13-14) : 14S - 14S
[23] Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast
Honglin Ding
Ning Li
Xiaoning He
Bing Liu
Liming Dong
Yili Liu
International Urology and Nephrology, 2017, 49 : 1723 - 1730
[24] The novel specific type-4 phosphodiesterase inhibitor roflumilast mitigates experimental colitis in mice
Rieder, F
Siegmund, B
Lehr, HA
Bundschuh, DS
Endres, S
Eigler, A
GASTROENTEROLOGY, 2005, 128 (04) : A203 - A203
[25] Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast
Ding, Honglin
Li, Ning
He, Xiaoning
Liu, Bing
Dong, Liming
Liu, Yili
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (10) : 1723 - 1730
[26] A role for phosphodiesterase type-4 inhibitors in COPD?
Johnson, DC
LANCET, 2001, 358 (9278): : 256 - 257
[27] Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
Giembycz, Mark A.
Field, Stephen K.
DRUG DESIGN DEVELOPMENT AND THERAPY, 2010, 4 : 147 - 158
[28] Roflumilast -: Antiallergy/antiasthmatic -: Treatment of COPD -: Phosphodiesterase 4 inhibitor
Sorbera, LA
Leeson, PA
Castañer, J
DRUGS OF THE FUTURE, 2000, 25 (12) : 1261 - 1264
[29] New options in a newly assessed COPD: PDE4 inhibitor treats obstruction and inflammation
不详
ALLERGOLOGIE, 2006, 29 (06) : 258 - 259
[30] Effect of a selective phosphodiesterase 4 (PDE4) inhibitor on hyperoxia toxicity in rat
Mehats, C.
Franco, M-L
Boucherat, O.
Schmitz, T.
Bourbon, J. R.
Delacourt, C.
Jarreau, P-H
ACTA PAEDIATRICA, 2007, 96 : 42 - 43

← 1 2 3 4 5 →